23andme regeneron - Search News

News

Regeneron Pharmaceuticals to pay $256 million for 23andMe

Houston Chronicle on MSN · 8h

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase Monday.

ABC News on MSN · 1d

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

Mashable on MSN · 23h

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

On Monday, Regeneron Pharmaceuticals announced that it would acquire most of 23andMe's assets for $256 million. According to Regeneron Pharmaceuticals, the acquisition includes 23andMe's Personal Genome Service, Total Health and Research Services business lines, and the trove of customers' DNA samples and genetic data.

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

Daily Voice on MSN8h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results